Matinas BioPharma Holdings, Inc.
MTNB
$0.62
$0.0294.91%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.71% | 0.61% | -10.85% | -13.25% | -9.26% |
| Total Depreciation and Amortization | 3.29% | 4.10% | 4.35% | 3.93% | 4.79% |
| Total Amortization of Deferred Charges | -115.89% | 101.89% | 5.94% | -58.25% | -49.29% |
| Total Other Non-Cash Items | 52.39% | -19.38% | -17.80% | -10.87% | -10.36% |
| Change in Net Operating Assets | -107.86% | -675.00% | 67.72% | 113.65% | 134.81% |
| Cash from Operations | -3.97% | -13.04% | -14.95% | 8.26% | 20.24% |
| Capital Expenditure | -- | 100.00% | 96.76% | 37.18% | 75.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.59% | 11.12% | -79.73% | 136.75% | 133.32% |
| Cash from Investing | -30.46% | 13.95% | -79.16% | 149.02% | 171.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 28.57% | 54.55% | 69.23% | 77.78% | 65.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 131,157.14% | 83,500.00% | 71,176.92% | 377.78% | -108.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 222.22% | 181.53% | -742.53% | 65.65% | 85.61% |